THE CLINICAL AND PATHOLOGIC SPECTRUM OF PERIPHERAL T CELL LYMPHOMAS NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


THE CLINICAL AND PATHOLOGIC SPECTRUM OF PERIPHERAL T CELL LYMPHOMAS

Hodgkin's Disease and Non-Hodgkin's Lymphomas in Adults and Children. Fuller LM et al, eds. New York, Raven, p. 381-401, 1988.. Unique Identifier : AIDSLINE ICDB/89649521
Riggs SA; Hagemeister FB; Dept. of Hematology, Univ. of Texas M.D. Anderson Hosp. and Tumor; Inst., Houston, TX 77030


Abstract: The various types of T-cell malignancies are reviewed and distinguished from one another, with an emphasis on clinical features and the treatment of patients with peripheral T-cell lymphoma, including adult T-cell leukemia-lymphoma. Variously described pathologic entities, probably variants of peripheral T-cell lymphoma, are discussed in relation to differential diagnosis of peripheral T-cell lymphoma. Diagnosis of peripheral T-cell lymphoma also is discussed as it relates to the Working Formulation, a classification that does not recognize any clinical differences between B-cell and T-cell lymphomas. Disease entities discussed are lymphoblastic lymphoma, mycosis fungoides and the Sezary syndrome, T-gamma lymphoproliferative disease, T-cell chronic lymphocytic leukemia, and peripheral T-cell lymphoma. The Working Formulation uses the Lukes-Collins terminology, which describes the appearance of tumor cells based on size and presence or absence of a cleaved nucleus, to classify lymphomas as diffuse small cleaved cell lymphoma, diffuse mixed cell lymphoma, diffuse large cell lymphoma, or immunoblastic sarcoma. The most important aspect of managing peripheral T-cell lymphoma is the establishment of the correct diagnosis. Besides correctly classifying the lymphoma within the confines of the Working Formulation, the pathologist should note that the diagnosis is compatible with peripheral T-cell lymphoma when epithelioid histiocytes are present and there is no evidence of a follicular component. Marker studies are essential when the lymphoma has a diffuse morphologic pattern to rule out B-cell lymphoma, even when the morphologic appearance suggests a T-cell lymphoma. (115 Refs)
Keywords: Diagnosis, Differential DNA, Neoplasm/GENETICS Granuloma, Lethal Midline/PATHOLOGY Human Immunoblastic Lymphadenopathy/PATHOLOGY Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/PATHOLOGY Leukemia, Lymphocytic, Chronic/PATHOLOGY Lymph Nodes/PATHOLOGY Lymphoma, Non-Hodgkin's/GENETICS/*PATHOLOGY Lymphomatoid Granulomatosis/PATHOLOGY Lymphoproliferative Disorders/PATHOLOGY Mycosis Fungoides/PATHOLOGY Sezary Syndrome/PATHOLOGY Skin Neoplasms/PATHOLOGY T-Lymphocytes/PATHOLOGY MONOGRAPH REVIEW REVIEW, TUTORIAL


890228
M8920513


Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .